Loading people...
John Dimos is the Vice President at Alexandria Venture Investments and the Head of Alexandria LaunchLabs in the San Francisco Bay Area. He joined the corporate venture capital arm of Alexandria Real Estate Equities in 2020 to oversee platform management, member recruitment, and regional ecosystem activities. Previously, Dimos served as the Chief Executive Officer of Fountain Therapeutics, a deep learning platform focused on aging-related diseases, and helped launch the early-stage life science investment bank Mavericks Capital. Before entering venture capital, he conducted stem cell research at Harvard University, where he was the lead author of a landmark 2008 study in the journal Science regarding ALS patient cells. Dimos, who holds a PhD from Princeton University and joined the StartOut National Programming Board in 2021, currently focuses on evaluating and supporting early-stage biotechnology and biopharma startups.
John T. Dimos is a distinguished Principal at Alexandria Venture Investments, a leading strategic venture capital platform dedicated to advancing the life science and technology sectors. In his pivotal role, Mr. Dimos is responsible for meticulously identifying, evaluating, and executing investments in groundbreaking companies poised for significant growth and innovation. His work directly contributes to Alexandria's mission of fostering a vibrant ecosystem for scientific and technological breakthroughs.
At Alexandria Venture Investments, Mr. Dimos primarily focuses on early-stage and growth-stage companies within the life science and technology domains. This includes a broad spectrum of areas such as biotechnology, pharmaceuticals, medical devices, diagnostics, and cutting-edge technology platforms that support these industries. He seeks out ventures that not only promise robust financial returns but also offer strategic value, aligning with Alexandria's extensive network of life science campuses and collaborative initiatives. His expertise lies in discerning disruptive technologies and business models that have the potential to reshape their respective markets.
Mr. Dimos's career background is deeply rooted in venture capital and company creation within the life sciences. Prior to joining Alexandria, he held a significant position as a Senior Associate at Flagship Pioneering, a renowned firm known for its unique approach to creating transformative biotechnology companies from the ground up. Before his tenure at Flagship, Mr. Dimos was a Senior Associate at Third Rock Ventures, another prominent venture capital firm focused on building innovative healthcare companies across various therapeutic areas. These experiences provided him with a comprehensive understanding of the entire lifecycle of biotech startups, from initial concept to strategic development and funding.
He began his professional journey as a consultant at ClearView Healthcare Partners, where he advised pharmaceutical, biotechnology, and medical device companies on critical aspects of corporate strategy, commercialization, and business development. This foundational experience equipped him with a strong analytical framework and a deep insight into the operational challenges and market dynamics of the healthcare industry. Academically, Mr. Dimos holds an MBA from The Wharton School of the University of Pennsylvania and a BS in Biomedical Engineering from Yale University, providing him with a robust blend of business acumen and scientific understanding essential for his role. While specific public notable investments are not typically disclosed for individual principals, his involvement with firms like Flagship Pioneering and Third Rock Ventures indicates a track record of contributing to the success of numerous high-impact life science ventures.
John T. Dimos is a Principal at Alexandria Venture Investments, a strategic venture capital platform. He specializes in identifying and evaluating innovative life science and technology companies for investment.
John T. Dimos primarily invests in early-stage and growth-stage life science and technology companies. His focus areas include biotechnology, pharmaceuticals, medical devices, diagnostics, and other cutting-edge technologies that offer strategic value and significant growth potential.
John T. Dimos works as a Principal at Alexandria Venture Investments. This organization is the strategic venture capital arm of Alexandria Real Estate Equities, Inc., a leading REIT focused on collaborative life science and technology campuses.
